Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
Surmodics Inc (NASDAQ:SRDX) has received a letter from the FDA related to its premarket approval (PMA) application for the SurVeil drug-coated…
Surmodics Provides Regulatory Update Related To Its FDA Premarket Approval Application For The SurVeil Drug-Coated Balloon
Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced it has received a letter from the U.S. Food and Drug Administration
Surmodics Sees FY23 Adj EPS Of $(2.54)-$(2.14) vs. Consensus of $(1.23)
Expects the fiscal year 2023 total revenue of $103 million - $107 million versus the consensus of $99.76 million
Surmodics: Q3 Earnings Insights
Surmodics (NASDAQ:SRDX) reported its Q3 earnings results on Wednesday, July 27, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
A Preview Of Surmodics’s Earnings
Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement.
Analysts estimate that Surmodics will report an earnings per share (EPS) of $-0.38.